Comparison of Denosumab and Bisphosphonates in Patients With Osteoporosis: A Meta-Analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Comparison of Denosumab and Bisphosphonates in Patients With Osteoporosis: A Meta-Analysis of Randomized Controlled Trials

Published:2018-12-10 Issue:5 Volume:104 Page:1753-1765
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Lyu Houchen¹²³^ORCID,Jundi Bakr²,Xu Chang³,Tedeschi Sara K²³,Yoshida Kazuki³⁴⁵,Zhao Sizheng³⁶,Nigwekar Sagar U⁷,Leder Benjamin Z⁸⁹,Solomon Daniel H³⁹¹⁰

Affiliation:

1. Department of Orthopedics, Chinese PLA General Hospital, Beijing, China

2. Department of Medicine, Harvard Medical School, Boston, Massachusetts

3. Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Boston, Massachusetts

4. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

5. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

6. Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom

7. Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts

8. Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts

9. Harvard Medical School, Boston, Massachusetts

10. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts

Funder

National Institutes of Health

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/104/5/1753/28319672/jc.2018-02236.pdf

Reference45 articles.

1. Clinician’s guide to prevention and treatment of osteoporosis;Cosman;Osteoporos Int,2014

2. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine;Wright;J Bone Miner Res,2014

3. Osteoporosis and the burden of osteoporosis-related fractures;Dempster;Am J Manag Care,2011

4. Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians;Qaseem;Ann Intern Med,2017

5. Bisphosphonates: mechanism of action and role in clinical practice;Drake;Mayo Clin Proc,2008

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [Translated article] Evaluation, differential diagnosis and treatment of vertebral osteoporosis: How to avoid the occurrence of new fractures;Revista Española de Cirugía Ortopédica y Traumatología;2024-08

2. Leitlinie Osteoporose 2023 – Differenzialtherapie – welches Medikament für wen?;rheuma plus;2024-06-25

3. Analysis of adverse drug reactions of Denosumab (Prolia) in osteoporosis based on FDA adverse event reporting system (FAERS);Frontiers in Pharmacology;2024-06-10

4. Evaluación, diagnóstico diferencial y tratamiento de la osteoporosis vertebral: cómo evitar la aparición de nuevas fracturas;Revista Española de Cirugía Ortopédica y Traumatología;2024-06

5. Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials;Osteoporosis International;2024-05-11